ArticleFrontiers in public health2025
Time to death and its predictors among HIV patients on antiretroviral therapy in public health facilities of Horro Guduru Wallaga zone, Ethiopia: a retrospective cohort study.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: People with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) continue to die at substantial rates, even in our nation of Ethiopia, despite receiving antiretroviral medication. Limited evidence is available regarding these individuals' time to death and its predictors. Therefore, this study aimed to evaluate time to death and its predictors among HIV/AIDS patients receiving antiretroviral therapy (ART) in this study area. Objective: The objective of the study was to assess time to death and its predictors among HIV patients receiving ART in public facilities of the Horro Guduru Wallaga (HGW) zone, Western Ethiopia, 2024. Methods and materials: A facility-based retrospective study was conducted involving 538 HIV-positive patients on anti-retroviral therapy. A simple random sampling method was used to select a sample from patient registrations between October 2018 and October 2023. Data were entered into EpiData version 3.1 and exported to STATA version 14. The Kaplan-Meier curve was used to estimate the survival probability after ART initiation. The Cox regression model was used to identify independent predictors of death. Significantly associated variables were reported with a Results: Among the 538 study participants included in the final analysis, 42 (8%) individuals died. The finding of this study revealed that the incidence rate of HIV-related death was 2.81 deaths per 1,000 person-months. Diarrhea (AHR = 4.54; 95% CI 1.85-11.13), failure to take TB prophylaxis (AHR = 5.61; 95%CI: 2.25, 14.03), non-utilization of condoms (AHR = 2.62; 95% CI: 1.13, 6.08), and WHO clinical stages III and IV (AHR = 7.02; 95%CI: 3.11, 11.84) were identified as predictors of death among the patients. Conclusion: The time to death among HIV patients on ART in this study area was higher compared to the national HIV-related death report. A history of diarrhea, failure to adhere to tuberculosis prophylaxis, non-utilization of condoms, and HIV clinical stages III and IV were found to be predictors of time to death related to HIV. Therefore, it is important to promote behavioral changes, such as condom utilization, adherence to TB prophylaxis, and effective treatment of comorbid infections, to improve the lifespan of HIV patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.